Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1950.640
- -7.202-0.37%
Close Sep 13 16:00 ET
1968.983High1947.773Low
1956.753Open1957.842Pre Close35.64MVolume6Rise70.07P/E (Static)3.60BTurnover--Flatline0.34%Turnover Ratio1.84TMarket Cap1Fall1.67TFloat Cap
Constituent Stocks: 7Top Rising: ALT+10.99%
Baird's optimism is driven by promising developments in Instil’s PD-L1xVEGF bispecific antibody, especially following positive data from peers like Akeso and Summit. Analysts believe this drug class has strong potentia...
FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis
Will the Sept curse come back to haunt us? Is it fading away? Or there will be a bull party instead? Nothing is for sure. Next week will likely be volatile entering the rate cut week.
Another day of profit from yesterday. Nice.
$Broadcom (AVGO.US)$ $NVIDIA (NVDA.US)$ $Alphabet-A (GOOGL.US)$ $Eli Lilly and Co (LLY.US)$ $Tesla (TSLA.US)$
going
down
again
LLY projected revenue next year is 59B
PFE last year's revenue is already 58B
LLY is close to 1T market value
PFE is 1/6 MV, 165B market value
it's either PFE is extremely undervalued or LLY is ridiculously overvalued!
Some good undervalued stocks are still up for grab. Glad that I have been holding some of them.
It’s hard to time and predict the market, but you can look at the trend for direction. Some good profit from yesterday.
$Alphabet-A (GOOGL.US)$ $Broadcom (AVGO.US)$ $Arm Holdings (ARM.US)$ $NVIDIA (NVDA.US)$ $Novo-Nordisk A/S (NVO.US)$
No comment yet